skip nav
National Prevention Information Network
Search Help
Other Searches: Search Organizations | Search Materials | Search Campaign Resources | Search Funding
Share Share this page on Twitter Share this page on Facebook Share this page on LinkedIn View more options to share this page E-mail this page to a colleague Print this page

<< Back


Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)

Grant Amount: Unspecified.

Scientific cooperation between India and the U.S. has taken place under a variety of bilateral umbrella agreements, including the Indo-U.S. Science and Technology (S&T) Sub-Commission, the Gandhi-Reagan S&T Initiative, the U.S.-India Fund, and the current S&T Cooperation Agreement. Building upon these agreements and initiatives, representatives of the United States and the Government of India signed a Memorandum of Understanding on July, 9 1987 implementing the Indo-U.S. Vaccine Action Program (VAP) in order to expand collaborative vaccine research. The goal of the VAP is to support collaborative vaccine-related research projects that ultimately reduce the burden of infectious diseases of importance in India, the U.S., the South Asian region, and globally. Applications are encouraged from organizations/institutions that propose to conduct vaccine-related research through U.S./Indo collaborations on the following: dengue, influenza (including avian influenza), malaria, enteric diseases, HIV/AIDS, and tuberculosis. Basic, translational, clinical, or epidemiological vaccine research may be proposed. Clinical trials will not be supported by this initiative.

This initiative offers to support VAP research activities and encourages research leading to the development of new and improved vaccines and related products and technologies to combat important infectious diseases of importance in India, the U.S., the South Asian region and globally. While applicants should provide evidence of ongoing or proposed scientific collaborations specific to the research proposed in the grant application, this initiative will not require joint application, review and funding of applications by the U.S. and India as was required in previous VAP-supported research projects. Standard NIH application and review procedures will be followed. NIAID will fund the grants supported by this FOA.

Basic, translational, clinical, or epidemiological vaccine research may be proposed under this program.
Funding Organization
National Institute of Allergy and Infectious Diseases
Division of Microbiology and Infectious Diseases
Fund Category
Other Health-Related
Support Types
Fund Location Note
Only U.S. and India Organizations are eligible to apply.
Eligible Organizations
City Agencies
Commercial Organizations
Community Based Organizations
County Agencies
Educational Organizations/Institutions
Federal Government Agencies
International Agencies
IRS 501 (c)(3) Organizations
Nonprofit Organizations
Religious Organizations
State Agencies
Tribal Organizations
Award Amount Notes
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Budgets for direct costs of up to $50,000 per year and a project duration of up to two years may be requested for a maximum of $100,000 direct costs over a two-year project period.

Application Due Date
Project Start Date
Application Contact
Phone: (301) 435-0714
Technical Contact
Edward McSweegan
NIAIDDivision of Microbiology
& Infectious Diseases

Phone: (301) 402-8370
Fund Duration
2 years.
Clinical Research
Epidemiological Research
HIV/AIDS Prevention
International Cooperation
TB Prevention
Vaccine Development Research
Application Process
Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in this FOA or following the directions provided at

It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide (, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
For AIDS Application due date, visit:

Web Site
Fund Number

Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN. Fund Record #4701

<< Back

Contact Us
About Us
HIV Content Notice
Privacy Policy
Policies & Disclaimers
Site Index
Help Using the CDC NPIN Web Site

CDC NPIN Searches

Search Organizations
Search Materials
Search Funding Opportunities
Search Campaign Resources
Help Using the CDC NPIN Searches

CDC NPIN Resources
STD Awareness Microsite
AIDS Gov Logo and Link CDC Logo and Link